1. Home
  2. FNKO vs CRBP Comparison

FNKO vs CRBP Comparison

Compare FNKO & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Funko Inc.

FNKO

Funko Inc.

HOLD

Current Price

$3.50

Market Cap

174.1M

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$8.30

Market Cap

170.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNKO
CRBP
Founded
2017
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.1M
170.3M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FNKO
CRBP
Price
$3.50
$8.30
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$7.13
$50.29
AVG Volume (30 Days)
645.8K
496.2K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$928,842,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$10.54
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.22
$4.64
52 Week High
$14.65
$20.56

Technical Indicators

Market Signals
Indicator
FNKO
CRBP
Relative Strength Index (RSI) 64.86 30.77
Support Level $2.95 $7.97
Resistance Level $3.11 $8.51
Average True Range (ATR) 0.17 0.62
MACD 0.03 -0.02
Stochastic Oscillator 97.35 8.99

Price Performance

Historical Comparison
FNKO
CRBP

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: